MC 1456 Dextran carboxyl, [carboxyl-14C]- |
|
| Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| (C6H10O5)nCOOH | |
| Solid | Please Inquire for Pricing |
| > 0.5 mCi(18.5 MBq)/g | |
| NextGen V-Vial | |
| M.W. 70,000 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 2002 Methoxydextran, [methyl-14C]- Click here for Typical Certificate of Analysis |
|
| Delivered ≥ 95% pure with dated HPLC radiochromatogram | |
| (C6H10O5)nCH3 | |
| Solid | 50 μCi (1.85 MBq) $3970 |
| > 0.5 mCi(18.5 MBq)/g | 250 μCi (9.25 MBq) $5170 |
| NextGen V-Vial | |
| M.W. 10,000 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 1457 Dextran carboxyl sulfate, [carboxyl-14C]- |
|
| Delivered ≥ 95% pure with dated HPLC radiochromatogram | |
| Solid | 250 μCi (9.25 MBq) $4320 |
| > 0.2 mCi(7.4 MBq)/g | |
| NextGen V-Vial | |
| M.W. 8,000 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |